Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines.

To obtain information regarding the growth-inhibitory effect of 1,25-dihydroxyvitamin D3 and its non-calcaemic analogue 22-oxa-1,25-dihydroxyvitamin D3 on pancreatic cancer cell lines, differences in the effects of G1-phase cell cycle-regulating factors were studied in vitamin D-responsive and non-responsive cell lines. Levels of expression of cyclins (D1, E and A), cyclin-dependent kinases (2 and 4) and cyclin-dependent kinase inhibitors (p21 and p27) were analysed by Western blotting after treatment with these compounds. In the responsive cells (BxPC-3, Hs 700T and SUP-1), our observations were: (1) marked up-regulation of p21 and p27 after 24 h treatment with 10(-7) mol l(-1) 1,25-dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3; and (2) marked down-regulation of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors after 7 days' treatment. In non-responsive cells (Hs 766T and Capan-1), no such changes were observed. In conclusion, vitamin D analogues up-regulate p21 and p27 as an early event, which in turn could block the G1/S transition and induce growth inhibition in responsive cells.

• Publication year

  1997

• Venue

  British Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.1997.479PMID 9328147PMCID 2228067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.

  1996cited by this paper
• Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines.

  1996cited by this paper
• Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

  1996cited by this paper
• New pancreas cancers cell lines that represent distinct stages of ductal differentiation.

  1995cited by this paper
• Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase

  1995cited by this paper
• p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.

  1995cited by this paper
• Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD

  1995cited by this paper
• 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a Noncalcemic Analogue of 1α,25-Dihydroxyvitamin D3, Inhibits Azoxymethane-induced Colonic Tumorigenesis

  1995cited by this paper
• p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

  1995cited by this paper
• 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1 alpha,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis.

  1995cited by this paper
• Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

  1994cited by this paper
• Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53.

  1994cited by this paper
• 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

  1994cited by this paper
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

  1994cited by this paper
• Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.

  1994cited by this paper
• Induction of p21 (WAF-1/CIP1) during differentiation.

  1994cited by this paper
• Cell cycle. Stifled by inhibitions.

  1994cited by this paper
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

  1994cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• Growth inhibition of human keratinocytes by 1,25-dihydroxyvitamin D3 is linked to dephosphorylation of retinoblastoma gene product.

  1993cited by this paper
• 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen.

  1993cited by this paper
• Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit

  1993cited by this paper
• A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.

  1991cited by this paper
• Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.

  1987cited by this paper
• Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia

  1987cited by this paper
• SYNTHETIC STUDIES OF VITAMIN D ANALOGUES. VII. : SYNTHESIS OF 20-OXA-21-NORVITAMIN D3 ANALOGUES

  1986cited by this paper
• Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues.

  1986cited by this paper
• 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.

  1983cited by this paper
• Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.

  1983cited by this paper
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

  1981cited by this paper
• A restriction point for control of normal animal cell proliferation.

  1974cited by this paper
• SYNTHETIC STUDIES ON VITAMIN A

  1958cited by this paper

• Current Controversies on Adequate Circulating Vitamin D Levels in CKD

  2025cites this paper
• Higher serum vitamin D concentration and supplementation were associated with improved survival outcomes and treatment response in cancer patients receiving immunotherapy: A systematic review and meta-analysis.

  2025cites this paper
• Determination and assessing the role of serum calcium, vitamin D, ferritin, and uric acid levels on prostate cancer risk.

  2025cites this paper
• Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies

  2024cites this paper
• The therapeutic potential of vitamins A, C, and D in pancreatic cancer

  2024cites this paper
• Vitamin D and Pancreatic Ductal Adenocarcinoma—A Review of a Complicated Relationship

  2024cites this paper
• Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state

  2024cites this paper
• Malignes Melanom und Adipositas: eine Übersichtsarbeit

  2023cites this paper
• Vitamin B12 enhances the antitumor activity of 1,25-dihydroxyvitamin D3 via activation of caspases and targeting actin cytoskeleton.

  2022cites this paper
• Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells

  2022cites this paper
• Impact of pulses, starches and meat on vitamin D and K postprandial responses in mice.

  2022cites this paper
• Malignes Melanom und Adipositas: eine Übersichtsarbeit

  2022cites this paper
• Lipophilic and Hydrophilic Compounds from Arthrospira platensis and Its Effects on Tissue and Blood Cells—An Overview

  2022cites this paper
• Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells

  2021cites this paper
• Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches

  2021cites this paper
• Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System

  2021cites this paper
• Vitamin D in human health

  2020cites this paper
• Burst, Short, and Sustained Vitamin D3 Applications Differentially Affect Osteogenic Differentiation of Human Adipose Stem Cells

  2020cites this paper
• Stories of drug repurposing for pancreatic cancer treatment—Past, present, and future

  2020cites this paper
• Relevance of Vitamin D in Melanoma Development, Progression and Therapy

  2019cites this paper
• Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes.

  2018cites this paper
• Vitamin intake and pancreatic cancer risk reduction

  2018cites this paper
• Tamoxifen inhibits fibroblast proliferation and prevents epidural fibrosis by regulating the AKT pathway in rats.

  2018cites this paper
• Pancreatic Cancer Epidemiology and Environmental Risk Factors

  2018cites this paper
• Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

  2017cites this paper
• Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation

  2017cites this paper
• Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications

  2017cites this paper
• Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis

  2017cites this paper
• Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells.

  2016cites this paper
• Effects of calcitriol on the growth of PANC-1 cell line with vitamin D receptor ( VDR ) gene silencing

  2016cites this paper
• Environmental risk factors for pancreatic cancer: an update

  2016cites this paper
• Mechanistic Insights of Vitamin D Anticancer Effects.

  2016cites this paper
• The role of vitamin D signalling in the interaction between mesenchymal mammary tumour cells and macrophages

  2016influential citation
• PLGA nanoparticles as a platform for vitamin D-based cancer therapy

  2015cites this paper
• Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer

  2015cites this paper
• PLGA nanoparticles for calcitriol delivery

  2015cites this paper
• Mechanistic Effects of Calcitriol in Cancer Biology

  2015cites this paper
• Simultaneous presentation of pancreatic cancer in a genetically unrelated couple

  2015cites this paper
• Pancreatic cancer control: is vitamin D the answer?

  2015cites this paper
• Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.

  2015cites this paper
• Vitamin D and pancreatic cancer.

  2015cites this paper
• Role of vitamin D in uterine fibroid biology.

  2015cites this paper
• LEIOMYOMAS PREVALENCE IN AFRICAN AMERICANS

  2015cites this paper
• Estudo da deficiência de vitamina D no modelo de isquemia/reperfusão renal em ratos

  2014cites this paper
• The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells.

  2014cites this paper
• Activation of Vitamin D Receptor Signaling Downregulates the Expression of Nuclear FOXM1 Protein and Suppresses Pancreatic Cancer Cell Stemness

  2014cites this paper
• LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.

  2014cites this paper
• Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo

  2013cites this paper
• Vitamin D and cancer

  2013cites this paper
• Einfluss unterschiedlicher UV-Bestrahlungssysteme auf den 25-Hydroxyvitamin D-Serumspiegel und andere Gesundheitsparameter

  2013cites this paper
• Antiproliferative effect of 1α,25-dihydroxyvitamin D3 involves upregulation of cyclin-dependent kinase inhibitor p21 in human pancreatic cancer cells.

  2013cites this paper
• Vitamin D in the prevention and treatment of pancreatic cancer

  2013cites this paper
• The Anti-cancer Actions of Vitamin D Anti-Cancer Agents in Medicinal Chemistry

  2012influential citation
• Assessment of the free binding energy of 1,25-dihydroxyvitamin D3 and its analogs with the human VDR receptor model.

  2012cites this paper
• Effect of 25‐hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines

  2012cites this paper
• Vitamin D and cancer: a review of molecular mechanisms.

  2012cites this paper
• The anti-cancer actions of vitamin D.

  2012cites this paper
• The Role of Vitamin D in the Prevention and Treatment of Prostate Cancer

  2011cites this paper
• 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.

  2011cites this paper
• Vitamin D in Oncology

  2011cites this paper
• Vitamin D effects on differentiation and cell cycle

  2011cites this paper
• LA VITAMINE D : SES PROPRIETES ET SON UTILISATION EN MEDECINE HUMAINE

  2011cites this paper
• Vitamin D and Pancreatic Cancer—An Update

  2011cites this paper
• The Anti-tumor Effects of Vitamin D in Other Cancers

  2011cites this paper
• Diabetes, pancreatic cancer and vitamin D. Is there a link?

  2011cites this paper
• Chemoprevention strategies for pancreatic cancer

  2010cites this paper
• Assessing the efficacy of the Hedgehog pathway inhibitor vitamin D3 in a murine xenograft model for pancreatic cancer

  2010cites this paper
• High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy.

  2009cites this paper
• Vitamin D for the prevention and treatment of pancreatic cancer.

  2009cites this paper
• Molecular actions of vitamin D contributing to cancer prevention.

  2008cites this paper
• 19-nor-1α,25-Dihydroxyvitamin D2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo

  2008cites this paper
• Vitamin D for the treatment and prevention of pancreatic cancer.

  2008cites this paper
• Molecular basis of the potential of vitamin D to prevent cancer

  2008cites this paper
• Vitamin D Receptor Gene Polymorphism and Risk of Oral Squamous Cell Carcinoma

  2008cites this paper
• Vitamin D Intake and the Risk for Pancreatic Cancer in Two Cohort Studies

  2006influential citation
• Chmp1 is Implicated in the Development of Pancreatic Tumor Via the Retinoic Acid Signaling Pathway

  2006cites this paper
• CHAPTER 25 – Pancreatic Cancer

  2006cites this paper
• Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines

  2005cites this paper
• CHAPTER 92 – Differentiation and the Cell Cycle

  2005cites this paper
• Vitamin D and skin cancer: a problem in gene regulation.

  2005cites this paper
• Vitamin D and cancer: an update of in vitro and in vivo data.

  2005cites this paper
• 1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness.

  2005cites this paper
• Sunlight and reduced risk of cancer: is the real story vitamin D?

  2005cites this paper
• Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines.

  2005cites this paper
• Nuclear Vitamin D Receptor: Structure-Function, Molecular Control of Gene Transcription, and Novel Bioactions

  2005cites this paper
• Vitamin D and skin cancer.

  2004cites this paper
• The role of ceramide in growth arrest and terminal differentiation of human leukaemia cells

  2004cites this paper
• 1,25-Dihydroxyvitamin D3 in lipiodol for the treatment of hepatocellular carcinoma: cellular, animal and clinical studies.

  2004cites this paper
• International Research Conference on Food, Nutrition, and Cancer

  2004cites this paper
• Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3.

  2004cites this paper
• Pancreatic cancer cells express 25-hydroxyvitamin D-1α-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3

  2004cites this paper
• Schizophrenia, vitamin D, and brain development.

  2004cites this paper
• Molecular Genetics of Hyperparathyroidism

  2004cites this paper
• Vitamin D Receptor Is Expressed in Pancreatic Cancer Cells and a Vitamin D3 Analogue Decreases Cell Number

  2003cites this paper
• Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer.

  2003cites this paper
• 1,25-Dihydroxyvitamin D3 induced cell cycle arrest in the human primary liver cancer cell line HepG2

  2003cites this paper
• Vitamin D and systemic cancer: is this relevant to malignant melanoma?

  2002cites this paper
• 1Alpha,25-dihydroxyvitamin D(3) - not just a calciotropic hormone.

  2002cites this paper
• Vitamin D and vitamin D analogs in cancer treatment.

  2002cites this paper
• 1α,25-Dihydroxyvitamin D3 – Not Just a Calciotropic Hormone

  2002cites this paper